Xgeva Solution for Injection

Dr. Emily Brown

Dr. Ryan Mitchell

## What is Xgeva injection

Xgeva is a prescription-only injection used to prevent major bone problems in individuals with advanced Cancer that has spread to their bones, as well as to treat giant cell tumors of the bone. The active salt is Denosumab (120 mg/1.7 mL).

Denosumab is a human monoclonal IgG2 antibody created using recombinant DNA technology and the first FDA-approved Receptor Activator of Nuclear factor Kappa-Β ligand (RANKL) inhibitor. It is produced by Amgen Inc. in a manufacturing unit that adheres to GMP quality standards.

Xgeva binds to RANKL, blocking its interaction with RANKL on osteoclasts, which are responsible for bone resorption. This, in turn, helps delay cancer-induced bone loss. Main applications include prevention of skeletal-related occurrences (pathological fractures, spinal cord compression, radiation or bone surgery) in people with advanced bone Cancers and Osteoporosis in postmenopausal women.

The standard dose is 120 mg, administered subcutaneously (under the skin) every 4 weeks by a healthcare provider. The missed dose should be administered as soon as possible. Seek urgent medical attention if you experience overdose symptoms, such as severe Hypocalcemia (critically low blood calcium).

Frequently reported side effects are fatigue, nausea, low calcium levels (Hypocalcemia), and bone or joint pain. Get emergency help if you have difficulty breathing, severe jaw pain, or signs of low calcium, such as muscle cramps or numbness.

Patients with very low blood calcium levels, a known allergic reaction to Denosumab or its components, or those who are pregnant should not use this medicine. Extra care is needed for patients who have serious dental issues, kidney problems, or have previously experienced Osteonecrosis (bone tissue death in the jaw). Keep refrigerated at 2°C–8°C; do not freeze.

## What are the benefits of taking Xgeva injection

The active salt in Xgeva is Denosumab, a monoclonal antibody that acts by inhibiting a protein called RANKL. This action delays bone breakdown, enhances bone strength, and reduces the risk of bone loss due to Cancer or Osteoporosis-related conditions.

When administered under medical supervision, Xgeva offers the following benefits:

Prevents bone fractures in Cancer patients with bone metastasis

Reduces elevated calcium levels induced by Cancer.

Strengthens weak and frail bones.

Overcome Osteoporosis in postmenopausal women.

Minimizes the likelihood of spinal cord compression and bone problems.

Helps to slow the development of bone damage in Multiple Myeloma and some tumors.

Improves mobility and lowers bone discomfort in many people.

## How to take Xgeva injection

To maximize the efficacy of the medication, always follow the instructions given by your doctor. However, some general usage guidelines are:

Stick to the schedule suggested by your doctor to ensure consistent results.

Xgeva is administered subcutaneously by a certified healthcare provider, typically in the upper arm, upper thigh, or abdomen.

Never self-administer or adjust the dose without medical supervision.

The standard dose is 120 mg every 4 weeks, which can be adjusted by your doctor depending on the severity and type of the condition being treated.

## Strengths and Substitutes

Cheap Medicine Shop presently stocks only one strength of Xgeva. If your prescription mentions a different dosage, consider exploring the following substitutes after consulting your doctor to ensure their safety for your specific health:

View all substitutes

## What are the side effects of Xgeva injection

Common side effects of Xgeva are:

Nausea

Fatigue

Headache

Back pain

Upper respiratory tract infections

These effects are usually mild and fade as the body adjusts to the medicine. Consult a doctor if symptoms persist or worsen.

## Safety Advice

Liver Disease

Liver patients can use Xgeva if prescribed by a healthcare expert. Although no major liver-related dose adjustments are usually needed, regular monitoring and medical guidance are recommended for individuals with severe liver impairment.

Kidney Impairment

Patients with mild to moderate kidney issues can generally take Xgeva if their doctor recommends it. However, individuals with advanced Chronic Kidney Disease (CKD) or on dialysis should exercise extreme caution and reach out to their medical provider to reduce the likelihood of severe Hypocalcemia and other complications.

Pregnant and Breastfeeding women

Pregnant women must strictly avoid Xgeva, as it can harm the developing fetus. Effective contraception is suggested during treatment and for at least five months after the last dose to prevent pregnancy-related complications. Also, its use while breastfeeding is prohibited due to a lack of safety data.

Avoid

Avoid combining alcohol with Xgeva, as excessive intake accelerates bone density loss, directly opposing Xgeva’s mechanism, significantly increasing Osteoporosis progression and dangerous fracture risk.

## FAQs

## What is the Xgeva injection used for?

Xgeva is used to prevent bone complications such as fractures and spinal cord compression in Cancer patients with bone metastases. It also treats Osteoporosis in postmenopausal women, giant cell tumor of bone, and Cancer-related high calcium levels by slowing bone breakdown and strengthening bones.

## How to give Xgeva injection?

Xgeva is given as a subcutaneous injection under the skin of the upper arm, thigh, or abdomen by a healthcare provider. The usual dose is 120 mg every 4 weeks. Patients could also need calcium and vitamin D supplements during treatment.

## How much calcium should be taken with Xgeva?

Patients using Xgeva are usually advised to take at least 500 mg of calcium and 400 IU of vitamin D daily, unless otherwise directed by a doctor. Supplements help reduce the risk of low calcium levels during Denosumab treatment.

## How long can Xgeva be given?

Xgeva is administered as long as the patient continues to benefit from treatment, typically every 4 weeks indefinitely. Doctors usually continue therapy as long as it effectively controls bone complications and the benefits outweigh potential risks or side effects.

## Can Xgeva be given every 3 months?

No, Xgeva is typically given as 120 mg every 4 weeks, not every 3 months, for its approved uses. However, any schedule change should be made only by the prescribing doctor.

## How long does Xgeva stay in your system?

After a single 120 mg subcutaneous dose, Denosumab has an estimated half-life of approximately 25–28 days, meaning Xgeva can remain active in your system for roughly 4–5 months before being fully eliminated.

## Is Xgeva chemo or immunotherapy?

Xgeva is neither chemotherapy nor immunotherapy. It is a targeted bone-modifying agent, a monoclonal antibody that blocks RANKL to prevent bone destruction caused by Cancer. It treats bone complications but does not directly attack or kill Cancer cells.